FLORETYROSINE F-18
| Brand name | PIXCLARA |
|---|---|
| Active ingredient | FLORETYROSINE F-18 |
| Strength | 5-300mCi/ML |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | September 2026 |
| Marketing status | RX |
| Code | Expires |
|---|---|
| NCE | September 2031 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.